Pharmacologic Inhibition of ROCK2 Suppresses Amyloid-β Production in an Alzheimer's Disease Mouse Model
Jeremy H. Herskowitz(University of Alabama at Birmingham), James J. Lah(Emory University)
Cited by 147
Related Papers
A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer’s disease
|Nature Medicine|2021|365
Loss-of-function variants in ABCA7 confer risk of Alzheimer's disease
|Nature Genetics|2015|332
The Lipoprotein Receptor LR11 Regulates Amyloid β Production and Amyloid Precursor Protein Traffic in Endosomal Compartments
|Journal of Neuroscience|2006|281
Cerebrospinal fluid proteomics define the natural history of autosomal dominant Alzheimer’s disease
|Nature Medicine|2023|172
Rho Kinase Inhibition as a Therapeutic for Progressive Supranuclear Palsy and Corticobasal Degeneration
|Journal of Neuroscience|2016|90